Related Experiment Video

Updated: Nov 17, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.5K

[NCLX exchanger: An ambivalent role in colorectal cancer timeline]

Maxime Guéguinou1, Trayambak Pathak2, Alison Robert1

  • 1Université de Tours, Inserm UMR 1069, Nutrition, croissance et cancer (N2C), Faculté de médecine, 10 boulevard Tonnellé, 37000 Tours, France.

Medecine Sciences : M/S
|February 16, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

502
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.3K

Related Experiment Videos

Last Updated: Nov 17, 2025

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

502
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.3K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K

Articles linked to this work by shared authors, journal, and citation graph.

ORAI Ca2+ channels and STIM1 drive capillary-to-arteriole communication in neurovascular coupling.

Science signaling·2026

The ubiquitin-activating enzyme inhibitor TAK-243 activates store-operated Ca2+ channels independently of endoplasmic reticulum Ca2+ stores and enhances mitochondrial Ca2+ buffering capacity in DU-145 human prostate cancer cells.

Biochimica et biophysica acta. Molecular cell research·2026

A Quartet of Native Orai Channel Isoforms Orchestrates Graded NFAT Activation and Transcription.

bioRxiv : the preprint server for biology·2026

Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026

Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium Cations.

Angewandte Chemie (International ed. in English)·2026

Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

[Serial cloners of Yamanashi].

Medecine sciences : M/S·2026

[Long COVID: between a syndromic framework and an etiological imperative].

Medecine sciences : M/S·2026

[The Edmonton transplantation protocol, 25 years later: toward remission of type 1 diabetes?]

Medecine sciences : M/S·2026

[Bioinformatics and omics analyses: chronology of a new scientific approach].

Medecine sciences : M/S·2026

[The 2025 Nobel Prize: regulatory T lymphocytes, the long-neglected "immunosuppressive cells". A brief history of a scientific renaissance and its emergence in France].

Medecine sciences : M/S·2026

[Contributions of seeding amplification assays to the diagnosis of synucleinopathies].

Medecine sciences : M/S·2026

Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study.

Gynecologic oncology·2026

Case Report: Diagnostic pitfall and biomarker-guided therapy in CD20-negative Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Frontiers in immunology·2026

Multimodality evaluation of bilateral parotid oncocytomas: A rare case report and literature review.

Radiology case reports·2026

Cribriform tumors of the skin: CD38 expression distinguishes from histologic mimics in a multi-institutional series.

Virchows Archiv : an international journal of pathology·2026

Gastric amphicrine carcinoma in the stomach: an unexpected presentation of MUTYH-associated polyposis.

Journal of pathology and translational medicine·2026

Limitations of evaluating risks of all cancers combined in etiological epidemiology research.

Global epidemiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us